Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti‐phospholipid syndrome

NK Singh, DR Behera, A Agrawal… - International Journal …, 2013 - Wiley Online Library
Aim To study the clinical and immunological features of primary antiphospholipid syndrome
(APS), and to analyze the differences between primary APS and APS associated with …

Antiphospholipid syndrome,“the best prophet of the future”

O Amengual, T Atsumi - Modern rheumatology, 2018 - academic.oup.com
The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
occurrence of venous and arterial thromboses, often multiple, and obstetric-related adverse …

How to identify high-risk APS patients: clinical utility and predictive values of validated scores

K Oku, O Amengual, S Yasuda, T Atsumi - Current Rheumatology Reports, 2017 - Springer
Abstract Purpose of Review Antiphospholipid syndrome (APS) is a clinical disorder
characterised by thrombosis and/or pregnancy morbidity in the persistence of …

Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?

A Ghirardello, A Doria, A Ruffatti, AM Rigoli… - Annals of the …, 1994 - ard.bmj.com
OBJECTIVE--Antiphospholipid antibody (aPL) specificity for aPL-related events was
evaluated in systemic lupus erythematosus (SLE). METHODS--A study was carried out on …

Clinical profiles and risk assessment in patients with antiphospholipid antibodies

M Kato, R Hisada, T Atsumi - Expert review of clinical immunology, 2019 - Taylor & Francis
Introduction: Antiphospholipid syndrome (APS) is an acquired autoimmune thrombophilia
associated with the presence of persistent antiphospholipid antibodies (aPL). Owing to …

14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends

D Erkan, CL Aguiar, D Andrade, H Cohen… - Autoimmunity …, 2014 - Elsevier
Antiphospholipid Syndrome (APS) is characterized by vascular thrombosis and/or
pregnancy morbidity occurring in patients with persistent antiphospholipid antibodies (aPL) …

Antiphospholipid antibodies and lower extremity peripheral artery disease: a systematic review and meta-analysis

M Merashli, T Bucci, D Pastori, P Pignatelli… - Seminars in Arthritis and …, 2020 - Elsevier
Aim To evaluate the clinical relevance of antiphospholipid antibodies (aPL) in patients with
lower extremity peripheral artery disease (PAD). Data sources EMBASE and MEDLINE …

[PDF][PDF] Antiphospholipid syndrome

R Cervera, JC Piette, J Font, MA Khamashta… - Arthritis …, 2002 - academia.edu
Antiphospholipid Syndrome Page 1 ARTHRITIS & RHEUMATISM Vol. 46, No. 4, April 2002, pp
1019–1027 DOI 10.1002/art.10187 © 2002, American College of Rheumatology Antiphospholipid …

Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series

SA Mahmud, DR Bullock, CK Correll, PM Hobday… - Pediatric …, 2022 - Springer
Background Non-criteria antiphospholipid antibodies (NC-aPL) are a relatively undefined
subgroup of antiphospholipid antibodies (aPL). Knowledge about NC-aPL in adults is …

[HTML][HTML] Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?

Y Ioannou, T Beukelman, M Murray… - European Journal of …, 2023 - ncbi.nlm.nih.gov
Antiphospholipid syndrome is a systemic autoimmune disorder characterized by vascular
thrombosis and/or obstetric events in association with persistently elevated antiphospholipid …